Cart
sales@molnova.com
gamma-secretase modulator 1
CAS No. 1172637-87-4
gamma-secretase modulator 1( N-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4-phenyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine )
Catalog No. M26225 CAS No. 1172637-87-4
gamma-secretase modulator 1 is a modulator of γ secretase and can be used in studies about the treatment of Alzheimer's disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 29 | In Stock |
|
| 5MG | 43 | In Stock |
|
| 10MG | 77 | In Stock |
|
| 25MG | 151 | In Stock |
|
| 50MG | 237 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namegamma-secretase modulator 1
-
NoteResearch use only, not for human use.
-
Brief Descriptiongamma-secretase modulator 1 is a modulator of γ secretase and can be used in studies about the treatment of Alzheimer's disease.
-
Descriptiongamma-secretase modulator 1 is a modulator of γ secretase and can be used in studies about the treatment of Alzheimer's disease.
-
In Vitro——
-
In Vivo——
-
SynonymsN-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4-phenyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine
-
PathwayNeuroscience
-
TargetGamma-secretase
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1172637-87-4
-
Formula Weight416.54
-
Molecular FormulaC24H24N4OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cc(Nc2nc3C(CCCc3s2)c2ccccc2)ccc1-n1cnc(C)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Huang J, Zhou Z, Zhou M, Miao M, Li H, Hu Q. Development of benzoxazole deoxybenzoin oxime and acyloxylamine derivatives targeting innate immune sensors and xanthine oxidase for treatment of gout. Bioorg Med Chem. 2018 May 1;26(8):1653-1664.
molnova catalog
related products
-
Aβ-IN-1
Aβ-IN-1 is a novel, potent and orally active γ-secretase modulator (GSM). Aβ-IN-1 potently reduced Aβ42 levels with an IC 50 value of 0.091 μM in cultured cells without inhibiting CYP3A4. Aβ-IN-1 shows a sustained pharmacokinetic profile.
-
Brontictuzumab
Brontictuzumab (OMP 52M5) is a monoclonal antibody that targets Notch1 and inhibits activation of the pathway.
-
BI-1408
BI-1408 is a modulator potent of γ secretase (IC50: 0.04 μM for Aβ42).
